Vergent Bioscience
PrivateLast Round
Grant
Nov 29, 2022
Total Funding Raised
$32.2M
Company Overview
Vergent Bioscience is a biotechnology company that develops tumor-targeted fluorescent imaging agents to improve the visibility of tumors for surgeons during minimally invasive and robotic-assisted surgery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vergent Bioscience Comparables
Compare Vergent Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blaze Bioscience, Inc. | 93% | |
| On Target Laboratories | 89% | |
| Avelas Biosciences | 84% | |
Vergent Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 29, 2022 | ||||
| Series B | Oct 4, 2022 | ||||
| Series A | Jun 12, 2018 |
Key People
Founding team and executive leadership
Vergent Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Orlando Health Ventures | Series B |
| Windham Capital Partners | Series B |
| Spring Mountain Capital | Series A |
| Rex Health Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2024
Grew 27% QoQ from 11 to 14 employees.
- Oct 4, 2022
$22M round led by Orlando Health Ventures.
Vergent Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vergent Bioscience's valuation, stock price, and market status.